Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Treatment Response in Immune-mediated Myositis Associated Rapidly-progressing Interstitial Lung Disease

NCT07775235 is registered in ClinicalTrials.gov with Singapore General Hospital as lead sponsor.

NCT NCT07775235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07775235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Treatment Response in Immune-mediated Myositis Associated Rapidly-progressing Interstitial Lung Disease
Lead sponsor
Singapore General Hospital
Phase
Observational
Overall status
Recruiting
Start date
December 26, 2024
Completion date
July 1, 2029
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease, myositis